NCT06071052View on ClinicalTrials.gov

TACE Plus HAIC Combined With Regorafenib for Liver Metastasis of Colorectal Cancer Refractory to Standard Treatment Regimens

NANot yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

November 1, 2024

Study Completion Date

November 1, 2024

Conditions

Liver Metastasis Colon Cancer

Interventions

PROCEDURE

TACE and HAIC Combined With Regorafenib

TACE and HAIC Combined With Regorafenib for Liver Metastasis of Colorectal Cancer who failed the second line treatment regimens

Trial Locations (1)

510000

the first affiliated hospital, Sun-Yat sen university, Guangzhou

All Listed Sponsors

lead

First Affiliated Hospital, Sun Yat-Sen University

OTHER

NCT06071052 - TACE Plus HAIC Combined With Regorafenib for Liver Metastasis of Colorectal Cancer Refractory to Standard Treatment Regimens | Biotech Hunter | Biotech Hunter